A Comparative Dissolution Kinetics Test for Omeprazole-Containing Medicines, Reproducing Secretory and Motor-Evacuatory Impairments the Stomach of Patients with Acid-Dependent Diseases


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

A comparative dissolution kinetics test was used to study the release (dissolution kinetics) of an original and 10 generic formulations of omeprazole from different manufacturers in a medium simulating the moderately acidic conditions in the stomach typical of the state of medication-induced suppression of acidity; tests were also performed in a model of pathological duodenogastric reflux. HPLC was used to measure omeprazole concentrations in aliquots collected at 4, 10, 15, 20, 30, 45, and 60 min in solution with pH 7.0 ± 0.05 after 2 h of exposure at pH 1.2 ± 0.05 or 4.0 ± 0.05. The duration of action of pathological duodenogastric reflux on the therapeutic formulations of omeprazole was 4 min. Not all the study formulations could be completely recognized as equivalents to the original formulation in the in vitro test conditions.

About the authors

G. F. Vasilenko

Scientific Center for Expert Evaluation of Medical Products, Ministry of Health of the Russian Federation

Email: chem@folium.ru
Russian Federation, Building 2, 8 Petrovskii Boulevard, Moscow, 127051

L. M. Krasnykh

Scientific Center for Expert Evaluation of Medical Products, Ministry of Health of the Russian Federation

Email: chem@folium.ru
Russian Federation, Building 2, 8 Petrovskii Boulevard, Moscow, 127051

S. Yu. Serebrova

Scientific Center for Expert Evaluation of Medical Products, Ministry of Health of the Russian Federation; I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University)

Email: chem@folium.ru
Russian Federation, Building 2, 8 Petrovskii Boulevard, Moscow, 127051; Building 2, Moscow

A. B. Prokof’ev

Scientific Center for Expert Evaluation of Medical Products, Ministry of Health of the Russian Federation; I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University)

Email: chem@folium.ru
Russian Federation, Building 2, 8 Petrovskii Boulevard, Moscow, 127051; Building 2, Moscow

G. V. Ramenskaya

Scientific Center for Expert Evaluation of Medical Products, Ministry of Health of the Russian Federation; I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University)

Email: chem@folium.ru
Russian Federation, Building 2, 8 Petrovskii Boulevard, Moscow, 127051; Building 2, Moscow

E. A. Smolyarchuk

I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University)

Email: chem@folium.ru
Russian Federation, Building 2, Moscow

D. O. Kurguzova

I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University)

Email: chem@folium.ru
Russian Federation, Building 2, Moscow

A. O. Barkov

I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University)

Email: chem@folium.ru
Russian Federation, Building 2, Moscow


Copyright (c) 2017 Springer Science+Business Media, LLC, part of Springer Nature

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies